Cleveland BioLabs
Buffalo · Founded 2003
About Cleveland BioLabs
Cleveland BioLabs is a clinical-stage biotech developing a robust pipeline of drugs for multiple medical and defense applications, with a focus on oncology and tissue protection. The company pursues the research, development, and commercialization of proprietary products that have the potential to treat cancer, prevent, and treat acute radiation syndrome and counteract the toxic effects of radio and chemotherapies for oncology patients. Cleveland BioLabs was established in 2003 and is headquartered in Buffalo, New York.
Company Facts
- Founded: 2003
- Operating status: Active
- Company type: For Profit
- IPO status: Delisted
- Employees: 51 – 100
- Estimated revenue: Less than $1M
- Total funding: $111.1M
- Funding stage: M&A
- Last round: Post-IPO Equity (Feb 2021)
- Ticker: nasdaq:CBLI
- Website: cbiolabs.com
- Phone: 7168496820
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/cleveland-biolabs-170551 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.